| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/22/2000 | US6027923 Primers used in each of the primer extension reactions of the process contain non-replicable elements that halt nucleic acid synthesis and thereby prevent the synthesized molecules from serving as templates in subsequent cycles |
| 02/22/2000 | US6027915 Expression augmenting sequence elements (EASE) for eukaryotic expression systems |
| 02/22/2000 | US6027914 Cytokine response (cr) genes |
| 02/22/2000 | US6027913 Synthesizing a polypeptide encoded by a sequence of interest in vitro |
| 02/22/2000 | US6027909 Bacillus strain and sporulation assay method |
| 02/22/2000 | US6027906 Dna molecules coding for the said penicillin binding protein (pbp) variants, as well as vectors containing them; assaying and designing therapeutically useful compounds which have high affinity to pbp |
| 02/22/2000 | US6027905 Methods for the detection of cervical cancer |
| 02/22/2000 | US6027904 Measuring the amount of thrombospondin or beta-thromboglobulin in the sample and determining the platelet count of the individual from the measured amount |
| 02/22/2000 | US6027901 CYP7 promoter-binding factors |
| 02/22/2000 | US6027899 Determining the predisposition of a human subject to develop late-onset alzheimer's disease, by detecting the presence or absence of a gene for butyrylcholinesterase k varient, its presence indicates an increased propensity to alzheimer's |
| 02/22/2000 | US6027898 Chromatographic method for mutation detection using mutation site specifically acting enzymes and chemicals |
| 02/22/2000 | US6027897 Promoter-primer mediated nucleic acid amplification |
| 02/22/2000 | US6027896 Providing a prognosis in subjects previously diagnosed with alzheimer's by identifying the apolipoprotein e type isoforms; then providing prognosis based on the presence or absence of an apolipoprotein e type 4 (apoe4) isoform |
| 02/22/2000 | US6027895 Methods for cleaving DNA with nucleotide integrases |
| 02/22/2000 | US6027894 Nucleic acid adapters containing a type IIs restriction site and methods of using the same |
| 02/22/2000 | US6027893 Two different nucleic acid analogues hybridizing to relatively short target sequences adjacently located on the nucleic acid to be identified; sensitive and specific determination |
| 02/22/2000 | US6027891 Method of early detection of HPV-associated carcinomas and extreme dysplasias caused by HPV |
| 02/22/2000 | US6027890 Detecting ligand binding by incubating tagged members with biological sample, separating bound from unbound members, cleaving tag, then detecting by non-fluorescent spectroscopy or potentiometry |
| 02/22/2000 | US6027889 Coupling of the ligase detection reaction and the polymerase chain reaction permits multiplex detection of nucleic acid sequence differences |
| 02/22/2000 | US6027886 Sample containing rna is hybridized with probes complementary to the sequence to be determined carrying a detectable group; admixing with an agent which cleaves the single stranded polynucleotide and the probe is determined after transfer |
| 02/22/2000 | US6027885 Method for electrochemiluminescent labeling of nucleic acid, use in detection, and compositions therefor |
| 02/22/2000 | US6027884 Thermodynamics, design, and use of nucleic acid sequences |
| 02/22/2000 | US6027883 Optimal procedure for isolation of mutant mitochondrial alleles |
| 02/22/2000 | US6027881 Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence |
| 02/22/2000 | US6027880 Arrays of nucleic acid probes and methods of using the same for detecting cystic fibrosis |
| 02/22/2000 | US6027879 Hybridize target sequences with probe capable of hybridizing to target sequence, detectable markers and a first complexing agent which can form a binding pair with second complexing agent; isolate and immobilize the hybridized target |
| 02/22/2000 | US6027878 A nucleic acid sequence; diagnosis of helicobacter infections, ulcers and gastrointestinal disorders |
| 02/22/2000 | US6027877 Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, purification of amplified DNA samples and allele identification |
| 02/22/2000 | US6027876 Method for monitoring pesticide resistance |
| 02/22/2000 | US6027875 Receptor infection assay |
| 02/22/2000 | US6027734 To provide protection against pneumococcal colonization and systemic infection, intranasally administering a composition consisting essentially of pneumococcal surface protein a or a fragment containing a protection-eliciting epitope |
| 02/22/2000 | US6027729 An isolated polypeptide comprising an amino acid sequence of at least 12 contiguous amino acids encoded by a non-a, non-b hepatitis virus, i.e., hepititis c, genome; managing infection spread; medical diagnosis; evaluation of library |
| 02/22/2000 | US6027709 Fluorescent cyanine dyes |
| 02/22/2000 | US6027692 Useful for diagnosis of diabetes |
| 02/22/2000 | US6027690 Used for determining the concentration of free l-carnitine and esterified l-carnitine in blood serum or plasma, and calculating the ratio of esterified and free l-carnitine for diagnosis of premansural syndrome |
| 02/22/2000 | CA2208707C Novel aminooligosaccharide derivative and process for preparing the same |
| 02/22/2000 | CA2137170C Nutrient medium for microbial culture |
| 02/22/2000 | CA2091882C Gene therapy for cystic fibrosis |
| 02/22/2000 | CA2074214C Improvements in the in situ pcr |
| 02/22/2000 | CA1340907C Synthetic antigen evoking anti-hiv responese |
| 02/17/2000 | WO2000008469A1 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis c virus protease |
| 02/17/2000 | WO2000008468A1 Method of determining cell or tissue type by transmembrane receptor identifiers |
| 02/17/2000 | WO2000008465A2 Method for determining the state of materials containing keratin and suitable devices and means therefor |
| 02/17/2000 | WO2000008444A1 Fluorescent assay for biological systems |
| 02/17/2000 | WO2000008443A1 Multiple frequency fluorescence lifetime imaging |
| 02/17/2000 | WO2000008215A1 Predicting the outcome of virus infections |
| 02/17/2000 | WO2000008214A1 Oligonucleotide analogs having modified dimers |
| 02/17/2000 | WO2000008213A1 Oligomers which inhibit expression of collagen genes |
| 02/17/2000 | WO2000008212A1 Gel microdrops in genetic analysis |
| 02/17/2000 | WO2000008211A2 Methods and compositions for modulating 'marginally indiscriminant' hybridizations |
| 02/17/2000 | WO2000008210A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 02/17/2000 | WO2000008209A2 Nucleic acids encoding human tbc-1 protein and polymorphic markers thereof |
| 02/17/2000 | WO2000008208A2 Reverse transcription and amplification processes and primers therefor |
| 02/17/2000 | WO2000008207A1 Uric acid assay device with stabilized uricase reagent composition |
| 02/17/2000 | WO2000008206A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 02/17/2000 | WO2000008205A1 Modelling organic compound reactivity in cytochrome p450 mediated reactions |
| 02/17/2000 | WO2000008204A2 Process for identification of substances modulating urei dependent mechanisms of helicobacter pylori metabolism |
| 02/17/2000 | WO2000008203A1 Method of monitoring bacterial contamination of a wound |
| 02/17/2000 | WO2000008199A1 Molecular cloning of a 7tm receptor (gpr31a) |
| 02/17/2000 | WO2000008182A1 Herpesvirus preparations and their uses |
| 02/17/2000 | WO2000008181A2 Chp polypeptide, a ligand of pak65 |
| 02/17/2000 | WO2000008180A2 HUMAN cDNAs ENCODING POLYPEPTIDES HAVING KINASE FUNCTIONS |
| 02/17/2000 | WO2000008179A1 Ikr-1 and ikr-2, protein kinases which are related to the i kappa b kinases |
| 02/17/2000 | WO2000008178A2 Murine dna molecules encoding polypeptides having kinase functions |
| 02/17/2000 | WO2000008177A2 Death associated kinase containing ankyrin repeats (dakar) |
| 02/17/2000 | WO2000008173A1 Identification and functional characterization of a novel ribosomal s6 protein kinase |
| 02/17/2000 | WO2000008171A1 N-acetylglycosaminyl transferase genes |
| 02/17/2000 | WO2000008169A1 Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants |
| 02/17/2000 | WO2000008164A2 Thermostable in vitro complex with polymerase activity |
| 02/17/2000 | WO2000008160A2 A plant disease resistance signalling gene: materials and methods relating thereto |
| 02/17/2000 | WO2000008154A1 Pancreatic and ovarian polypeptide, zsig58 |
| 02/17/2000 | WO2000008149A2 Human neuronal acid-sensitive cationic channels, its cloning and applications |
| 02/17/2000 | WO2000008147A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses |
| 02/17/2000 | WO2000008144A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3 |
| 02/17/2000 | WO2000008137A2 Transgenic animals having a modified glycoprotein v gene |
| 02/17/2000 | WO2000008136A1 Method for enzymatic amplification of nucleic acid |
| 02/17/2000 | WO2000008133A1 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE |
| 02/17/2000 | WO2000008054A1 Modified green fluorescent protein |
| 02/17/2000 | WO2000008041A1 Structural analogs of amine bases and nucleosides |
| 02/17/2000 | WO2000007728A2 Micro-system with multiple points for chemical or biological analysis |
| 02/17/2000 | WO2000007632A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 02/17/2000 | WO2000007577A2 Phosphatidylcholine as a medicament for the protection of mucosa |
| 02/17/2000 | WO2000007545A2 Apoptosis proteins |
| 02/17/2000 | WO2000007437A1 A method of identifying and recovering products exuded from a plant |
| 02/17/2000 | WO2000007434A1 Novel genetic materials for transmission into maize |
| 02/17/2000 | WO2000001815A3 Neurotrophic factors |
| 02/17/2000 | WO2000000637A3 Method for sequencing nucleic acids with reduced errors |
| 02/17/2000 | WO1999061601A3 Aav5 vector and uses thereof |
| 02/17/2000 | WO1999058675A3 Human genes and gene expression products v |
| 02/17/2000 | WO1999057321A9 Method of determining the nucleotide sequence of oligonucleotides and dna molecules |
| 02/17/2000 | WO1999057317A9 Electronic methods for the detection of analytes utilizing monolayers |
| 02/17/2000 | WO1999057241A9 Myelin basic protein peptides and uses thereof |
| 02/17/2000 | WO1999055859A3 Cd40-interacting and traf-interacting proteins |
| 02/17/2000 | WO1999054729A3 Immobilized substrate, separation gels and method for detecting enzymatic activity |
| 02/17/2000 | WO1999053036A9 Ste20-related protein kinases |
| 02/17/2000 | WO1999051779A9 Glaucoma therapeutics and diagnostics |
| 02/17/2000 | WO1999051756A9 Promoter and constructions for expression of recombinant proteins in filamentous fungi |
| 02/17/2000 | WO1999050461A9 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 02/17/2000 | WO1999049803A9 Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation |
| 02/17/2000 | WO1999032663A3 High throughput assay system |